Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Artificial Cobweb Proteins For Medicine

30.05.2005


A unique material based on cobweb proteins is being created by Russian researchers of the State Research Center of Russian Federation GosNIIgentics, Scientific Research Center “Coal-Chemical Fiber”, State Research Center of Applied Microbiology in cooperation with their colleagues from Michigan University with support form the International Science and Technology Center (ISTC) (project 1033.2).



The spider’s hunting net is built from several different proteins. Researchers are mostly interested in the proteins of cobweb framework filaments, which make them extremely strong (the rupture strength of these filaments is several times higher than that of steel) and elastic at the same time. Cobweb framework filaments consist of two proteins: spidroin-1 and spidroin-2. They differ slightly in their properties: spidroin-1 is considered to be stronger, and spidroin-2 – more elastic. Together they account for unique properties of spider’s web. Such material would prove useful for multiple purposes, but fist of all – for medicine: as suture material, artificial ligaments and tendons, films for healing wounds and burns, etc.

Unfortunately, it is impossible to synthesize these proteins chemically in a laboratory – they are too complicated. However, it is possible to get the protein by synthesizing a respective gene and making it work within the composition of some microorganism. The scientists have chosen this particular biotechnological way.


At the first stage of the project (June 1999 through May 2000), the researchers focused on obtaining spidroin-1. The problem is that the structure of this protein has not been fully decoded, and the international database does not contain its complete amino acid sequence. Only fragments are available there. But the researchers decided to try and use the known fragment for the gene synthesis and obtaining a recombinant protein.

They succeeded in synthesizing the gene that codes the spidroin-1fragment, its size making 400 pairs of nucleotides. The gene contained in plasmid was transferred into Saccharomices cerevisiae yeast plants and made sure that the gene does work inside the yeast plant – the yeast produces protein. The researchers developed original methods for educing and rectifying recombinant proteins.With their help the scientists have already produced hundreds of milligrams of the product.

Refined protein should be dissolved, which is a complicated task as the protein solution of such concentration (40 percent) – 400 milligrams in one milliliter – cannot be received by ordinary methods. To dissolve the protein, sodium thiocyanate was used, thus providing the so-called spinning solution. A filament should be spun from it as a spider does. To this end, the researchers developed special methods and got a filament which, however, did not yet possess either cobweb’s strength or elasticity.

At the second stage of the project (2002 through 2004), the researchers started to work concurrently to also obtain recombinant spidroin-2. The structure of the most part of this protein is known, but it is extremely complicated. Before the gene for spidroin-2 could be synthesized, it was necessary to thoroughly analyze amino acids sequence in the molecule. Mathematicians addressed the issue and discovered periodically recurrent sequences in the chain. Thanks to that, it became possible to divide the molecule into monomeric units and to handle individual units.

“In such a way we assemble a gene, says Vladimir Bogush. This is a very lengthy work and it has not been finished yet. But our final goal is to get a complete analogue of the spidroin-2 natural gene.”

While the researchers are handling the spidroin-2 complicated gene, concurrently a recombinant protein – analogue to spidroin-2 – was received through synthesizing the gene that corresponds to one of its fragments (similar to the way they worked with spidroin-1). The scientists created a gene, inserted it into yeast plants and got the protein. In this case, however, the researchers applied a different species of yeast –Pichia pastoris, special culture of which ideally suits for biotechnological manipulations due to peculiar mutation.

Availability of protein in selected yeast plants is checked by electrophoresis method – a fascia appears on the plate, its position corresponding to its molecular mass.

The yeast grows and produces protein in a special apparatus - fermenter. Some days later, the cell suspension with finished product is partially poured off, fresh cultural medium is added, and the cycle is reiterated. Therefore, the process is called “quasi- continuous”.

At this stage, the researchers also improved the process of artificial spinning and learned to get a strong elastic filament. The filament was tested for strength on special devices by the specialists of the Scientific-Research Center “Coal-Chemical Fiber” in the town of Mytishchi. A filament being several microns thick can stand for rupture of 50 to 100 milligrams of weight. “Our filament has turned out to be only four times less strong than that of a spider, says Vladimir Bogush, project manager, and this is a very good result.”

The protein can be used to produce not only filaments but also films. In this form it is supposed to be used for production of healing coating for wounds and burns, which will not be rejected by the organism and will stimulate regeneration of its own epithelium. In the meanwhile, the films produced from recombinant protein were investigated for toxicity in experiments with cell culture. The conclusion made by the researchers is that the films are non-toxic.

When the researchers succeed to finalize the synthesis of a very complicated gene and to get a full natural analogue to spidroin-2, it will be possible to mix two proteins in different ratio changing the properties this or that way and to bring artificial spidery filament to perfection.

Sergey Komarov | alfa
Further information:
http://www.informnauka.ru

More articles from Life Sciences:

nachricht New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)

nachricht Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

New drug reduces transplant and mortality rates significantly in patients with hepatitis C

29.05.2017 | Statistics

VideoLinks
B2B-VideoLinks
More VideoLinks >>>